Growth in the live cell
imaging market can primarily be attributed to various factors such as the
growing adoption of high-content screening techniques in drug discovery, rising
incidence of cancer, and the growth in funding for research.
The Live Cell Imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9%.
+ Market Dynamics
+ Rising Adoption of
High-Content Screening Techniques in Drug Discovery
+ Rising Incidence of Cancer
+ Growing Availability of Funds for Research
Download PDF Brochure @
“By type, the microscopes segment is estimated to hold the largest share of the live cell imaging instruments market”
Based on type, the market is segmented into microscopes, standalone systems, cell analyzers, and accessories. In 2018, the microscopes segment accounted for the largest share of the live cell imaging instruments market. Increasing studies into cell behavior and the need to correlate multiple events and markers with cell morphology, favorable funding scenario for R&D in microscopy, rising focus on regenerative medicine, technological advancements in microscopes, and favorable regulatory procedures in order to launch new instruments in the market are the key factors driving the growth of the microscopes market.
“By type, the reagents segment is estimated to hold the largest share of the live cell imaging consumables market”
the basis of type, the global live cell imaging consumables market is segmented
into reagents, media, assay kits, and other consumables (microplates, slides,
petri dishes, cover slips, and culture chambers). In 2018, the reagents segment
accounted for the largest share of the consumables market. The large share of
this segment can be attributed to the growing applications of biosciences and
biotechnology within the pharmaceutical and healthcare fields.
View complete press release:-